parmar-ceuticals limited

parmar-ceuticals limited Company Information

Share PARMAR-CEUTICALS LIMITED
Live 
MatureSmallRapid

Company Number

03496193

Industry

Dispensing chemist in specialised stores

 

Shareholders

mr jai nagin parmar

mr nagin bhagwanji parmar

Group Structure

View All

Contact

Registered Address

1 tudor gardens, kingsbury, london, NW9 8RL

parmar-ceuticals limited Estimated Valuation

£725.3k

Pomanda estimates the enterprise value of PARMAR-CEUTICALS LIMITED at £725.3k based on a Turnover of £2.4m and 0.3x industry multiple (adjusted for size and gross margin).

parmar-ceuticals limited Estimated Valuation

£374.7k

Pomanda estimates the enterprise value of PARMAR-CEUTICALS LIMITED at £374.7k based on an EBITDA of £107.2k and a 3.5x industry multiple (adjusted for size and gross margin).

parmar-ceuticals limited Estimated Valuation

£1.6m

Pomanda estimates the enterprise value of PARMAR-CEUTICALS LIMITED at £1.6m based on Net Assets of £733.2k and 2.13x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Parmar-ceuticals Limited Overview

Parmar-ceuticals Limited is a live company located in london, NW9 8RL with a Companies House number of 03496193. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in January 1998, it's largest shareholder is mr jai nagin parmar with a 50% stake. Parmar-ceuticals Limited is a mature, small sized company, Pomanda has estimated its turnover at £2.4m with rapid growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Parmar-ceuticals Limited Health Check

Pomanda's financial health check has awarded Parmar-Ceuticals Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating5out of 5
positive_score

5 Strong

positive_score

3 Regular

positive_score

4 Weak

size

Size

annual sales of £2.4m, make it smaller than the average company (£12.6m)

£2.4m - Parmar-ceuticals Limited

£12.6m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 35%, show it is growing at a faster rate (7.6%)

35% - Parmar-ceuticals Limited

7.6% - Industry AVG

production

Production

with a gross margin of 27%, this company has a comparable cost of product (32.4%)

27% - Parmar-ceuticals Limited

32.4% - Industry AVG

profitability

Profitability

an operating margin of 4.3% make it more profitable than the average company (2.9%)

4.3% - Parmar-ceuticals Limited

2.9% - Industry AVG

employees

Employees

with 11 employees, this is below the industry average (75)

11 - Parmar-ceuticals Limited

75 - Industry AVG

paystructure

Pay Structure

on an average salary of £26.5k, the company has an equivalent pay structure (£26.5k)

£26.5k - Parmar-ceuticals Limited

£26.5k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £220.8k, this is more efficient (£143.9k)

£220.8k - Parmar-ceuticals Limited

£143.9k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 94 days, this is later than average (30 days)

94 days - Parmar-ceuticals Limited

30 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 33 days, this is quicker than average (64 days)

33 days - Parmar-ceuticals Limited

64 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 39 days, this is in line with average (34 days)

39 days - Parmar-ceuticals Limited

34 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 34 weeks, this is more cash available to meet short term requirements (14 weeks)

34 weeks - Parmar-ceuticals Limited

14 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 25.2%, this is a lower level of debt than the average (59.4%)

25.2% - Parmar-ceuticals Limited

59.4% - Industry AVG

PARMAR-CEUTICALS LIMITED financials

EXPORTms excel logo

Parmar-Ceuticals Limited's latest turnover from November 2023 is estimated at £2.4 million and the company has net assets of £733.2 thousand. According to their latest financial statements, Parmar-Ceuticals Limited has 11 employees and maintains cash reserves of £110.6 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Nov 2023Nov 2022Nov 2021Nov 2020Oct 2019Oct 2018Oct 2017Oct 2016Oct 2015Oct 2014Oct 2013Oct 2012Oct 2011Oct 2010Oct 2009
Turnover2,428,6371,224,8161,019,655979,320882,612939,745807,424865,735697,922621,255694,781716,642774,312821,2420
Other Income Or Grants000000000000000
Cost Of Sales1,774,098874,314734,035726,803651,068685,028582,707616,245511,506451,323499,617524,251571,870609,6670
Gross Profit654,539350,502285,620252,517231,544254,716224,717249,490186,416169,932195,164192,390202,442211,5760
Admin Expenses550,545205,841169,565186,293147,344259,630221,844169,294203,127204,667234,101203,047147,569143,239-348,045
Operating Profit103,994144,661116,05566,22484,200-4,9142,87380,196-16,711-34,735-38,937-10,65754,87368,337348,045
Interest Payable00000000000002,0122,012
Interest Receivable11,86510,9773182141,3131,228402379619682626400314272150
Pre-Tax Profit115,859155,638116,37366,43885,512-3,6863,27580,575-16,092-34,053-38,311-10,25755,18866,597346,183
Tax-28,965-29,571-22,111-12,623-16,2470-622-16,1150000-14,349-18,647-96,931
Profit After Tax86,894126,06794,26253,81569,265-3,6862,65364,460-16,092-34,053-38,311-10,25740,83947,950249,252
Dividends Paid000000000000000
Retained Profit86,894126,06794,26253,81569,265-3,6862,65364,460-16,092-34,053-38,311-10,25740,83947,950249,252
Employee Costs291,983265,846251,066229,125241,954242,741206,761195,75786,29987,15183,72684,15183,746100,6410
Number Of Employees11111111111211115555560
EBITDA*107,203147,404129,91679,90898,3699,12417,28495,274-800-17,782-22,3567,08762,67289,387365,168

* Earnings Before Interest, Tax, Depreciation and Amortisation

Nov 2023Nov 2022Nov 2021Nov 2020Oct 2019Oct 2018Oct 2017Oct 2016Oct 2015Oct 2014Oct 2013Oct 2012Oct 2011Oct 2010Oct 2009
Tangible Assets13,27711,85311,57011,30613,68913,60915,54718,65722,43327,04221,11825,77131,19838,99743,745
Intangible Assets22211,30322,60433,90545,20656,50767,80879,10990,410101,711113,012124,313135,614
Investments & Other000000000000000
Debtors (Due After 1 year)000000000000000
Total Fixed Assets13,27911,85511,57222,60936,29347,51460,75375,16490,241106,151111,528127,482144,210163,310179,359
Stock & work in progress194,285178,190175,728202,123195,258205,853177,484175,684156,547145,848137,242150,923170,101156,927167,461
Trade Debtors626,389243,282199,504178,595151,614143,913131,835131,04496,31586,380110,385116,144121,965132,3450
Group Debtors000000000000000
Misc Debtors0000000000000083,632
Cash110,624341,377390,423245,634183,237166,818160,719160,933141,944105,480167,37182,86176,95948,83859,885
misc current assets35,00035,00020,00020,00000000000000
total current assets966,298797,849785,655646,352530,109516,584470,038467,661394,806337,708414,998349,928369,025338,110310,978
total assets979,577809,704797,227668,961566,402564,098530,791542,825485,047443,859526,526477,410513,235501,420490,337
Bank overdraft000000000000000
Bank loan000000000000000
Trade Creditors 164,394119,661202,905184,777120,535182,257139,751161,656158,849116,482147,164136,032158,839199,5260
Group/Directors Accounts000000000000000
other short term finances000000000000000
hp & lease commitments000000000000000
other current liabilities00000000000000179,092
total current liabilities164,394119,661202,905184,777120,535182,257139,751161,656158,849116,482147,164136,032158,839199,526179,092
loans0000000000000061,893
hp & lease commitments000000000000000
Accruals and Deferred Income000000000000000
other liabilities82,02543,77974,12558,24973,74778,98684,49977,28186,77071,85789,78913,49416,2554,5920
provisions000000000000000
total long term liabilities82,02543,77974,12558,24973,74778,98684,49977,28186,77071,85789,78913,49416,2554,59261,893
total liabilities246,419163,440277,030243,026194,282261,243224,250238,937245,619188,339236,953149,526175,094204,118240,985
net assets733,158646,264520,197425,935372,120302,855306,541303,888239,428255,520289,573327,884338,141297,302249,352
total shareholders funds733,158646,264520,197425,935372,120302,855306,541303,888239,428255,520289,573327,884338,141297,302249,352
Nov 2023Nov 2022Nov 2021Nov 2020Oct 2019Oct 2018Oct 2017Oct 2016Oct 2015Oct 2014Oct 2013Oct 2012Oct 2011Oct 2010Oct 2009
Operating Activities
Operating Profit103,994144,661116,05566,22484,200-4,9142,87380,196-16,711-34,735-38,937-10,65754,87368,337348,045
Depreciation3,2092,7432,5602,3832,8682,7373,11011,3014,6105,6525,2806,4437,7999,7495,822
Amortisation0011,30111,30111,30111,30111,3013,77711,30111,30111,30111,301011,30111,301
Tax-28,965-29,571-22,111-12,623-16,2470-622-16,1150000-14,349-18,647-96,931
Stock16,0952,462-26,3956,865-10,59528,3691,80019,13710,6998,606-13,681-19,17813,174-10,534167,461
Debtors383,10743,77820,90926,9817,70112,07879134,7299,935-24,005-5,759-5,821-10,38048,71383,632
Creditors44,733-83,24418,12864,242-61,72242,506-21,9052,80742,367-30,68211,132-22,807-40,687199,5260
Accruals and Deferred Income0000000000000-179,092179,092
Deferred Taxes & Provisions000000000000000
Cash flow from operations-276,231-11,651131,41997,68123,29411,183-7,83428,10020,933-33,0658,2169,2794,84252,995196,236
Investing Activities
capital expenditure-4,633-3,026-2,8240-2,948-7990-1-1-11,576-627-1,01611,301-5,001-196,482
Change in Investments000000000000000
cash flow from investments-4,633-3,026-2,8240-2,948-7990-1-1-11,576-627-1,01611,301-5,001-196,482
Financing Activities
Bank loans000000000000000
Group/Directors Accounts000000000000000
Other Short Term Loans 000000000000000
Long term loans0000000000000-61,89361,893
Hire Purchase and Lease Commitments000000000000000
other long term liabilities38,246-30,34615,876-15,498-5,239-5,5137,218-9,48914,913-17,93276,295-2,76111,6634,5920
share issue00000000000000100
interest11,86510,9773182141,3131,228402379619682626400314-1,740-1,862
cash flow from financing50,111-19,36916,194-15,284-3,926-4,2857,620-9,11015,532-17,25076,921-2,36111,977-59,04160,131
cash and cash equivalents
cash-230,753-49,046144,78962,39716,4196,099-21418,98936,464-61,89184,5105,90228,121-11,04759,885
overdraft000000000000000
change in cash-230,753-49,046144,78962,39716,4196,099-21418,98936,464-61,89184,5105,90228,121-11,04759,885

parmar-ceuticals limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for parmar-ceuticals limited. Get real-time insights into parmar-ceuticals limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Parmar-ceuticals Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for parmar-ceuticals limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in NW9 area or any other competitors across 12 key performance metrics.

parmar-ceuticals limited Ownership

PARMAR-CEUTICALS LIMITED group structure

Parmar-Ceuticals Limited has no subsidiary companies.

Ultimate parent company

PARMAR-CEUTICALS LIMITED

03496193

PARMAR-CEUTICALS LIMITED Shareholders

mr jai nagin parmar 50%
mr nagin bhagwanji parmar 50%

parmar-ceuticals limited directors

Parmar-Ceuticals Limited currently has 2 directors. The longest serving directors include Mr Nagin Parmar (Jan 1998) and Mr Jai Parmar (Jan 1998).

officercountryagestartendrole
Mr Nagin Parmar82 years Jan 1998- Director
Mr Jai Parmar58 years Jan 1998- Director

P&L

November 2023

turnover

2.4m

+98%

operating profit

104k

0%

gross margin

27%

-5.82%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

November 2023

net assets

733.2k

+0.13%

total assets

979.6k

+0.21%

cash

110.6k

-0.68%

net assets

Total assets minus all liabilities

parmar-ceuticals limited company details

company number

03496193

Type

Private limited with Share Capital

industry

47730 - Dispensing chemist in specialised stores

incorporation date

January 1998

age

26

incorporated

UK

ultimate parent company

None

accounts

Unaudited Abridged

last accounts submitted

November 2023

previous names

N/A

accountant

AUCTUS ACCOUNTANTS LTD

auditor

-

address

1 tudor gardens, kingsbury, london, NW9 8RL

Bank

-

Legal Advisor

-

parmar-ceuticals limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 4 charges/mortgages relating to parmar-ceuticals limited. Currently there are 1 open charges and 3 have been satisfied in the past.

parmar-ceuticals limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for PARMAR-CEUTICALS LIMITED. This can take several minutes, an email will notify you when this has completed.

parmar-ceuticals limited Companies House Filings - See Documents

datedescriptionview/download